Page last updated: 2024-08-17

mannitol and pulmicort

mannitol has been researched along with pulmicort in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (45.83)29.6817
2010's12 (50.00)24.3611
2020's1 (4.17)2.80

Authors

AuthorsStudies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Anderson, SD; Brannan, JD; Chan, HK; Koskela, H1
Anderson, SD; Brannan, JD; Leuppi, JD1
Harjunen, P; Järvinen, K; Lankinen, T; Lehto, VP; Salonen, H1
Jhun, BH; Kim, DD; Kim, YS; Lee, CH; Lee, MK; Lee, SH; Roh, HJ; Yoo, JW1
Bolzen, N; Steckel, H1
Anderson, SD; Andersson, M; Bingisser, R; Brutsche, MH; Chan, HK; Greiff, L; Knoblauch, A; Leuppi, JD; Perruchoud, AP; Stolz, D; Surber, C; Tamm, M; Tandjung, R1
Björk, E; Ekelund, K; Johansson, F; Osth, K; Påhlstorp, C; Ulvenlund, S1
Cheruvu, NP; Kompella, UB1
Csepregi, A; Malfertheiner, P; Neumann, H; Sailer, M1
Caron, V; Descamps, M; Dudognon, E; Willart, JF1
Adi, H; Chan, HK; Heng, D; Kumon, M; Kwok, PC1
Chan, HK; Kwok, PC; Raper, JA; Tang, P; Tong, Z; Yang, R1
Chhajed, PN; Jochmann, A; Leuppi, JD; Maier, S; Miedinger, D; Schafroth Török, S; Scherr, A; Taegtmeyer, AB; Tamm, M1
Hindle, M; Longest, PW1
Halkola, T; Hirvonen, J; Järvinen, K; Kauppinen, EI; Laaksonen, T; Peltonen, L; Pessi, J; Rahikkala, A; Raula, J1
Rattanupatam, T; Srichana, T1
Chhajed, PN; Goll, A; Jochmann, A; Knöpfli, B; Leuppi, JD; Miedinger, D; Mueller, T; Sauter, S; Schafroth Török, S; Taegtmeyer, AB; Zellweger, LJ1
Buckton, G; Jones, MD1
Huang, Y; Huang, Z; Liao, Q; Pan, X; Peng, T; Wu, C; Wu, CY; Xu, J; Zhang, J; Zhang, X; Zhao, Z1
Foged, C; Leng, D; Thanki, K; Yang, M1
Birk, G; Hertel, N; Scherließ, R1

Reviews

2 review(s) available for mannitol and pulmicort

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Bronchial provocation tests: the rationale for using inhaled mannitol as a test for airway hyperresponsiveness.
    Swiss medical weekly, 2002, Apr-06, Volume: 132, Issue:13-14

    Topics: Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchodilator Agents; Budesonide; Forced Expiratory Volume; Humans; Mannitol; Saline Solution, Hypertonic

2002

Trials

1 trial(s) available for mannitol and pulmicort

ArticleYear
Response to add-on inhaled corticosteroids in COPD based on airway hyperresponsiveness to mannitol.
    Chest, 2012, Volume: 142, Issue:4

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Bronchial Hyperreactivity; Budesonide; Diuretics, Osmotic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Mannitol; Middle Aged; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Treatment Outcome

2012

Other Studies

21 other study(ies) available for mannitol and pulmicort

ArticleYear
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.
    Respirology (Carlton, Vic.), 2002, Volume: 7, Issue:1

    Topics: Administration, Inhalation; Adult; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchodilator Agents; Budesonide; Female; Forced Expiratory Volume; Humans; Male; Mannitol; Middle Aged; Pilot Projects; Time Factors

2002
Effects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPI.
    International journal of pharmaceutics, 2003, Sep-16, Volume: 263, Issue:1-2

    Topics: Albuterol; Budesonide; Chemistry, Pharmaceutical; Drug Carriers; Drug Storage; Glucose; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Lung; Mannitol; Nebulizers and Vaporizers; Powders

2003
Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies.
    Pharmaceutical research, 2003, Volume: 20, Issue:10

    Topics: Biological Transport; Budesonide; Carbon Radioisotopes; Cells, Cultured; Electric Conductivity; Epithelial Cells; Humans; Mannitol; Microscopy, Electron; Nasal Mucosa; Pharmaceutical Preparations; Pharmacokinetics

2003
Alternative sugars as potential carriers for dry powder inhalations.
    International journal of pharmaceutics, 2004, Feb-11, Volume: 270, Issue:1-2

    Topics: Administration, Inhalation; Budesonide; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Drug Carriers; Glucose; Maltose; Mannitol; Microscopy, Electron, Scanning; Nebulizers and Vaporizers; Particle Size; Powders; Sorbitol; Sugar Alcohols; Sweetening Agents; Xylitol

2004
Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept.
    Pulmonary pharmacology & therapeutics, 2005, Volume: 18, Issue:2

    Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Bronchial Provocation Tests; Bronchoconstrictor Agents; Bronchodilator Agents; Budesonide; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Histamine; Humans; Male; Mannitol; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Spirometry; Treatment Outcome; Vital Capacity

2005
Correlation between epithelial toxicity and surfactant structure as derived from the effects of polyethyleneoxide surfactants on caco-2 cell monolayers and pig nasal mucosa.
    Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:4

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Caco-2 Cells; Chemical Phenomena; Chemistry, Physical; Diffusion Chambers, Culture; Diuretics; Electric Impedance; Epithelial Cells; Humans; Light; Mannitol; Nasal Mucosa; Polyethylene Glycols; Propranolol; Scattering, Radiation; Structure-Activity Relationship; Surface Tension; Surface-Active Agents; Swine

2005
Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer.
    Investigative ophthalmology & visual science, 2006, Volume: 47, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Biological Transport; Bruch Membrane; Budesonide; Cattle; Celecoxib; Choroid; Diffusion Chambers, Culture; Fluorescein; Mannitol; Permeability; Pyrazoles; Rhodamines; Sclera; Sulfonamides; Swine; Water

2006
Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis.
    Journal of neurology, 2007, Volume: 254, Issue:6

    Topics: Acute Disease; Adjuvants, Immunologic; Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Budesonide; Drug Synergism; Glatiramer Acetate; Hepatitis, Autoimmune; Humans; Iatrogenic Disease; Interferon beta-1b; Interferon-beta; Liver; Male; Mannitol; Multiple Sclerosis; Mycophenolic Acid; Peptides; Treatment Outcome

2007
Transformation of pharmaceutical compounds upon milling and comilling: the role of T(g).
    Journal of pharmaceutical sciences, 2007, Volume: 96, Issue:5

    Topics: Anti-Inflammatory Agents; Budesonide; Chemistry, Pharmaceutical; Crystallization; Drug Compounding; Drug Stability; Excipients; Lactose; Mannitol; Models, Chemical; Sorbitol; Technology, Pharmaceutical; Transition Temperature; Trehalose; Water

2007
Can low-dose combination products for inhalation be formulated in single crystalline particles?
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2010, Apr-16, Volume: 40, Issue:1

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Androstadienes; Budesonide; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallization; Drug Combinations; Ethanolamines; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Humans; Mannitol; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Particle Size; Photoelectron Spectroscopy; Surface Properties; Transition Temperature; X-Ray Diffraction

2010
Does the United States Pharmacopeia throat introduce de-agglomeration of carrier-free powder from inhalers?
    Pharmaceutical research, 2012, Volume: 29, Issue:7

    Topics: Administration, Inhalation; Aerosols; Bronchodilator Agents; Budesonide; Dry Powder Inhalers; Equipment Design; Humans; Hydrodynamics; Mannitol; Particle Size; Powders; United States

2012
Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device.
    The Journal of pharmacy and pharmacology, 2012, Volume: 64, Issue:9

    Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Budesonide; Chemistry, Pharmaceutical; Citric Acid; Drug Combinations; Drug Delivery Systems; Excipients; Humans; Hydrophobic and Hydrophilic Interactions; Lung; Mannitol; Metered Dose Inhalers; Models, Anatomic; Nanoparticles; Particle Size; Respiratory Mucosa; Sodium Chloride

2012
Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate.
    International journal of pharmaceutics, 2013, Jan-30, Volume: 441, Issue:1-2

    Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Budesonide; Drug Combinations; Drug Compounding; Drug Delivery Systems; Excipients; Feasibility Studies; Glucocorticoids; Leucine; Mannitol; Nanoparticles; Nebulizers and Vaporizers; Particle Size; Solubility; Time Factors

2013
Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery.
    Drug delivery, 2014, Volume: 21, Issue:6

    Topics: Administration, Inhalation; Budesonide; Drug Carriers; Leucine; Mannitol; Particle Size; Powders; Spectroscopy, Fourier Transform Infrared

2014
An open-label study examining the effect of pharmacological treatment on mannitol- and exercise-induced airway hyperresponsiveness in asthmatic children and adolescents with exercise-induced bronchoconstriction.
    BMC pediatrics, 2014, Aug-02, Volume: 14

    Topics: Acetates; Administration, Inhalation; Adolescent; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Bronchial Provocation Tests; Bronchoconstrictor Agents; Bronchodilator Agents; Budesonide; Child; Cyclopropanes; Drug Administration Schedule; Exercise Test; Female; Forced Expiratory Volume; Humans; Male; Mannitol; Quinolines; Sulfides; Treatment Outcome; Young Adult

2014
Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.
    International journal of pharmaceutics, 2016, Jul-25, Volume: 509, Issue:1-2

    Topics: Adhesiveness; Administration, Inhalation; Albuterol; Beclomethasone; Budesonide; Chemistry, Pharmaceutical; Chromatography, Gas; Colloids; Drug Carriers; Dry Powder Inhalers; Erythritol; Lactose; Mannitol; Microscopy, Atomic Force; Particle Size; Pharmaceutical Preparations; Powders; Solubility; Terbutaline; Triamcinolone Acetonide

2016
Nanoporous mannitol carrier prepared by non-organic solvent spray drying technique to enhance the aerosolization performance for dry powder inhalation.
    Scientific reports, 2017, 05-02, Volume: 7

    Topics: Animals; Budesonide; Drug Carriers; Male; Mannitol; Nanoparticles; Particle Size; Porosity; Rats; Rats, Sprague-Dawley; Solvents

2017
Formulating Inhalable Dry Powders Using Two-Fluid and Three-Fluid Nozzle Spray Drying.
    Pharmaceutical research, 2018, Nov-01, Volume: 35, Issue:12

    Topics: Administration, Inhalation; Budesonide; Chemistry, Pharmaceutical; Desiccation; Dry Powder Inhalers; Excipients; Humans; Mannitol; Nanoparticles; Particle Size; Powders; Surface Properties; Technology, Pharmaceutical; Water

2018
Particle engineered mannitol for carrier-based inhalation - A serious alternative?
    International journal of pharmaceutics, 2020, Mar-15, Volume: 577

    Topics: Administration, Inhalation; Albuterol; Budesonide; Drug Carriers; Dry Powder Inhalers; Lactose; Mannitol; Mechanical Phenomena; Particle Size

2020